Contact this trialFirst, we need to learn more about you.
Glucagon-like peptide-1 receptor agonist
Exenatide for Gestational Diabetes
Recruiting3 awardsPhase 4
Pittsburgh, Pennsylvania
This trial studies the effects of exenatide to lower blood sugar in pregnant women with type II diabetes, and how it helps the pancreas secrete insulin. It may provide an alternate option to the current drug therapies.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.